0

Close
 
Upcoming Allied Market Research
2023
Intravenous Access Devices Market

Intravenous Access Devices Market

by PRODUCT (Intravenous Catheters, Centrally Inserted Catheters, Midline Peripheral Catheters, Intravenous Infusion Pumps, Intravenous Needles): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A00330
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Intravenous Access Devices Market

Request Now !

Intravenous Access Devices are a prominent sector of the Healthcare industry. These devices are used by physicians for treating patients as well as testing blood after withdrawing it via intravenous route. Intravenous access devices are used for administering all the classes of drugs like antibiotics, antipyretics and analgesics. Rising incidences of different diseases such as tuberculosis, cancer and others are the key drivers of this market. Moreover, urbanization and growing geriatric population all over the world boost the growth of the Intravenous (IV) Access Devices market. 

Growing development of new vaccines and use of advanced technology to design new products are another driver for the market. However, lenient government regulations for approving Intravenous (IV) insulin infusion pumps and risks associated with using needles are the major restraints of this market. Furthermore, rise in the number of patients and increased disposable incomes among emerging countries are the key opportunities for this market.

Global Intravenous Access Devices Market Analysis by Product

On the basis of its types, an intravenous access devices market is segmented into Intravenous Catheters, Intravenous Infusion Pumps and Intravenous Needles. It is further subcategorized by the type of products. Intravenous catheters are one of the promising segments of Global Intravenous access devices market and it is expected to grow at healthy CAGR due to the rising incidences of diseases such as tuberculosis and cancer and the growing geriatric population worldwide.

Global Intravenous Access Devices Market Analysis by Geography

The intravenous access devices market is segmented according to geography into North America, Europe, Asia-Pacific and LAMEA. The North American region holds the dominant share in this market due to growing geriatric population and patient pool. However, the Asia-pacific region would have a high growth rate due to rise in target diseases, growing geriatric population, significant healthcare expenditure, and improving healthcare infrastructure.

Competitive Analysis

The key companies profiled in this report are Becton, Dickinson & Company, B. Braun Melsungen AG, Teleflex Incorporated, Medtronic, Inc., Smiths Medical, Hospira, Inc., Covidien Plc, Fresenius Medical Care AG & Co., CareFusion Corporation and Baxter International. The key developmental strategies for these companies are improving medication management, lowering the cost of their products, lowering the risk of infection and partnering with their customers in healthcare industries.

HIGH LEVEL ANALYSIS

Analysis of the market based on Porter’s Five Force model suggests that the bargaining power of the supplier is high as the patient pool is growing and these devices are used for many treatments and for diagnosis purposes. Threat of new entrants is low as the capital investment required for this market is high. Growth in the IV access device market and rise in target diseases has increased the demand for these devices for consistent disease monitoring. This has shaped the platform for leading companies to gain more competencies in the market.

KEY BENEFITS

  • The market is segmented by type of product, which would enable a deeper understanding of the scope for this market.
  • Geographic segmentation would enable stakeholders to make region specific plans for growth in untapped regions.
  • Analysis provides an overview of the market like its drivers, opportunities and restraints. Moreover, Porter’s Five Force Model and SWOT analysis are strategically discussed for the global intravenous access devices market.
  • The analysis assists in understanding the strategies adopted by the companies for the growth of the intravenous access devices market.

 Intravenous Access Devices Market Report Highlights

Aspects Details
By PRODUCT
  • Intravenous Catheters
    • Midline Peripheral Catheter
    • Central Catheters
  • Centrally Inserted Catheters
  • Midline Peripheral Catheters
  • Intravenous Infusion Pumps
    • Parenteral Feeding Infusion Pumps
    • Intravenous Insulin Infusion pumps
    • Intravenous Syringe Infusion Pumps
    • Intravenous Patient Controlled Analgesia (PCA) Infusion Pumps
  • Intravenous Needles
By GEOGRAPHY
  • North America
  • Europe
  • Asia Pacific
  • LAMEA
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: INTRAVENOUS ACCESS DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Intravenous Catheters

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Midline Peripheral Catheter

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Central Catheters

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Centrally Inserted Catheters

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Midline Peripheral Catheters

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Intravenous Infusion Pumps

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

      • 4.5.4. Parenteral Feeding Infusion Pumps

        • 4.5.4.1. Market Size and Forecast

      • 4.5.4. Intravenous Insulin Infusion pumps

        • 4.5.4.1. Market Size and Forecast

      • 4.5.4. Intravenous Syringe Infusion Pumps

        • 4.5.4.1. Market Size and Forecast

      • 4.5.4. Intravenous Patient Controlled Analgesia (PCA) Infusion Pumps

        • 4.5.4.1. Market Size and Forecast

    • 4.6. Intravenous Needles

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: INTRAVENOUS ACCESS DEVICES MARKET, BY REGION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Region

    • 5.2. North America

      • 5.2.1. Key Market Trends and Opportunities

      • 5.2.2. Market Size and Forecast, By Product

      • 5.2.3. Market Size and Forecast, By Country

      • 5.2.4. U.S. Intravenous Access Devices Market

        • 5.2.4.1. Market Size and Forecast, By Product

      • 5.2.5. Canada Intravenous Access Devices Market

        • 5.2.5.1. Market Size and Forecast, By Product

      • 5.2.6. Mexico Intravenous Access Devices Market

        • 5.2.6.1. Market Size and Forecast, By Product

    • 5.3. Europe

      • 5.3.1. Key Market Trends and Opportunities

      • 5.3.2. Market Size and Forecast, By Product

      • 5.3.3. Market Size and Forecast, By Country

      • 5.3.4. France Intravenous Access Devices Market

        • 5.3.4.1. Market Size and Forecast, By Product

      • 5.3.5. Germany Intravenous Access Devices Market

        • 5.3.5.1. Market Size and Forecast, By Product

      • 5.3.6. Italy Intravenous Access Devices Market

        • 5.3.6.1. Market Size and Forecast, By Product

      • 5.3.7. Spain Intravenous Access Devices Market

        • 5.3.7.1. Market Size and Forecast, By Product

      • 5.3.8. UK Intravenous Access Devices Market

        • 5.3.8.1. Market Size and Forecast, By Product

      • 5.3.9. Russia Intravenous Access Devices Market

        • 5.3.9.1. Market Size and Forecast, By Product

      • 5.3.10. Rest Of Europe Intravenous Access Devices Market

        • 5.3.10.1. Market Size and Forecast, By Product

    • 5.4. Asia-Pacific

      • 5.4.1. Key Market Trends and Opportunities

      • 5.4.2. Market Size and Forecast, By Product

      • 5.4.3. Market Size and Forecast, By Country

      • 5.4.4. China Intravenous Access Devices Market

        • 5.4.4.1. Market Size and Forecast, By Product

      • 5.4.5. Japan Intravenous Access Devices Market

        • 5.4.5.1. Market Size and Forecast, By Product

      • 5.4.6. India Intravenous Access Devices Market

        • 5.4.6.1. Market Size and Forecast, By Product

      • 5.4.7. South Korea Intravenous Access Devices Market

        • 5.4.7.1. Market Size and Forecast, By Product

      • 5.4.8. Australia Intravenous Access Devices Market

        • 5.4.8.1. Market Size and Forecast, By Product

      • 5.4.9. Thailand Intravenous Access Devices Market

        • 5.4.9.1. Market Size and Forecast, By Product

      • 5.4.10. Malaysia Intravenous Access Devices Market

        • 5.4.10.1. Market Size and Forecast, By Product

      • 5.4.11. Indonesia Intravenous Access Devices Market

        • 5.4.11.1. Market Size and Forecast, By Product

      • 5.4.12. Rest of Asia Pacific Intravenous Access Devices Market

        • 5.4.12.1. Market Size and Forecast, By Product

    • 5.5. LAMEA

      • 5.5.1. Key Market Trends and Opportunities

      • 5.5.2. Market Size and Forecast, By Product

      • 5.5.3. Market Size and Forecast, By Country

      • 5.5.4. Brazil Intravenous Access Devices Market

        • 5.5.4.1. Market Size and Forecast, By Product

      • 5.5.5. South Africa Intravenous Access Devices Market

        • 5.5.5.1. Market Size and Forecast, By Product

      • 5.5.6. Saudi Arabia Intravenous Access Devices Market

        • 5.5.6.1. Market Size and Forecast, By Product

      • 5.5.7. UAE Intravenous Access Devices Market

        • 5.5.7.1. Market Size and Forecast, By Product

      • 5.5.8. Argentina Intravenous Access Devices Market

        • 5.5.8.1. Market Size and Forecast, By Product

      • 5.5.9. Rest of LAMEA Intravenous Access Devices Market

        • 5.5.9.1. Market Size and Forecast, By Product

  • CHAPTER 6: COMPETITIVE LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top Winning Strategies

    • 6.3. Product Mapping Of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Top Player Positioning,2022

  • CHAPTER 7: COMPANY PROFILES

    • 7.1. Company 1

      • 7.1.1. Company Overview

      • 7.1.2. Key Executives

      • 7.1.3. Company Snapshot

      • 7.1.4. Operating Business Segments

      • 7.1.5. Product Portfolio

      • 7.1.6. Business Performance

      • 7.1.7. Key Strategic Moves and Developments

    • 7.2. Company 2

      • 7.2.1. Company Overview

      • 7.2.2. Key Executives

      • 7.2.3. Company Snapshot

      • 7.2.4. Operating Business Segments

      • 7.2.5. Product Portfolio

      • 7.2.6. Business Performance

      • 7.2.7. Key Strategic Moves and Developments

    • 7.3. Company 3

      • 7.3.1. Company Overview

      • 7.3.2. Key Executives

      • 7.3.3. Company Snapshot

      • 7.3.4. Operating Business Segments

      • 7.3.5. Product Portfolio

      • 7.3.6. Business Performance

      • 7.3.7. Key Strategic Moves and Developments

    • 7.4. Company 4

      • 7.4.1. Company Overview

      • 7.4.2. Key Executives

      • 7.4.3. Company Snapshot

      • 7.4.4. Operating Business Segments

      • 7.4.5. Product Portfolio

      • 7.4.6. Business Performance

      • 7.4.7. Key Strategic Moves and Developments

    • 7.5. Company 5

      • 7.5.1. Company Overview

      • 7.5.2. Key Executives

      • 7.5.3. Company Snapshot

      • 7.5.4. Operating Business Segments

      • 7.5.5. Product Portfolio

      • 7.5.6. Business Performance

      • 7.5.7. Key Strategic Moves and Developments

    • 7.6. Company 6

      • 7.6.1. Company Overview

      • 7.6.2. Key Executives

      • 7.6.3. Company Snapshot

      • 7.6.4. Operating Business Segments

      • 7.6.5. Product Portfolio

      • 7.6.6. Business Performance

      • 7.6.7. Key Strategic Moves and Developments

    • 7.7. Company 7

      • 7.7.1. Company Overview

      • 7.7.2. Key Executives

      • 7.7.3. Company Snapshot

      • 7.7.4. Operating Business Segments

      • 7.7.5. Product Portfolio

      • 7.7.6. Business Performance

      • 7.7.7. Key Strategic Moves and Developments

    • 7.8. Company 8

      • 7.8.1. Company Overview

      • 7.8.2. Key Executives

      • 7.8.3. Company Snapshot

      • 7.8.4. Operating Business Segments

      • 7.8.5. Product Portfolio

      • 7.8.6. Business Performance

      • 7.8.7. Key Strategic Moves and Developments

    • 7.9. Company 9

      • 7.9.1. Company Overview

      • 7.9.2. Key Executives

      • 7.9.3. Company Snapshot

      • 7.9.4. Operating Business Segments

      • 7.9.5. Product Portfolio

      • 7.9.6. Business Performance

      • 7.9.7. Key Strategic Moves and Developments

    • 7.10. Company 10

      • 7.10.1. Company Overview

      • 7.10.2. Key Executives

      • 7.10.3. Company Snapshot

      • 7.10.4. Operating Business Segments

      • 7.10.5. Product Portfolio

      • 7.10.6. Business Performance

      • 7.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR CENTRALLY INSERTED CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR MIDLINE PERIPHERAL CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS INFUSION PUMPS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS NEEDLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. NORTH AMERICA INTRAVENOUS ACCESS DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. NORTH AMERICA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 10. U.S. INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 11. CANADA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 12. MEXICO INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 13. EUROPE INTRAVENOUS ACCESS DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. EUROPE INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 15. FRANCE INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 16. GERMANY INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 17. ITALY INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. SPAIN INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 19. UK INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 20. RUSSIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. REST OF EUROPE INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. ASIA-PACIFIC INTRAVENOUS ACCESS DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. ASIA-PACIFIC INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. CHINA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. JAPAN INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. INDIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. SOUTH KOREA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. AUSTRALIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. THAILAND INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. MALAYSIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. INDONESIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. REST OF ASIA PACIFIC INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. LAMEA INTRAVENOUS ACCESS DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 34. LAMEA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. BRAZIL INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 36. SOUTH AFRICA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. SAUDI ARABIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. UAE INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. ARGENTINA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. REST OF LAMEA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. COMPANY 1: KEY EXECUTIVES
  • TABLE 42. COMPANY 1: COMPANY SNAPSHOT
  • TABLE 43. COMPANY 1: OPERATING SEGMENTS
  • TABLE 44. COMPANY 1: PRODUCT PORTFOLIO
  • TABLE 45. COMPANY 1: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 46. COMPANY 2: KEY EXECUTIVES
  • TABLE 47. COMPANY 2: COMPANY SNAPSHOT
  • TABLE 48. COMPANY 2: OPERATING SEGMENTS
  • TABLE 49. COMPANY 2: PRODUCT PORTFOLIO
  • TABLE 50. COMPANY 2: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 51. COMPANY 3: KEY EXECUTIVES
  • TABLE 52. COMPANY 3: COMPANY SNAPSHOT
  • TABLE 53. COMPANY 3: OPERATING SEGMENTS
  • TABLE 54. COMPANY 3: PRODUCT PORTFOLIO
  • TABLE 55. COMPANY 3: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 56. COMPANY 4: KEY EXECUTIVES
  • TABLE 57. COMPANY 4: COMPANY SNAPSHOT
  • TABLE 58. COMPANY 4: OPERATING SEGMENTS
  • TABLE 59. COMPANY 4: PRODUCT PORTFOLIO
  • TABLE 60. COMPANY 4: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 61. COMPANY 5: KEY EXECUTIVES
  • TABLE 62. COMPANY 5: COMPANY SNAPSHOT
  • TABLE 63. COMPANY 5: OPERATING SEGMENTS
  • TABLE 64. COMPANY 5: PRODUCT PORTFOLIO
  • TABLE 65. COMPANY 5: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 66. COMPANY 6: KEY EXECUTIVES
  • TABLE 67. COMPANY 6: COMPANY SNAPSHOT
  • TABLE 68. COMPANY 6: OPERATING SEGMENTS
  • TABLE 69. COMPANY 6: PRODUCT PORTFOLIO
  • TABLE 70. COMPANY 6: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 71. COMPANY 7: KEY EXECUTIVES
  • TABLE 72. COMPANY 7: COMPANY SNAPSHOT
  • TABLE 73. COMPANY 7: OPERATING SEGMENTS
  • TABLE 74. COMPANY 7: PRODUCT PORTFOLIO
  • TABLE 75. COMPANY 7: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. COMPANY 8: KEY EXECUTIVES
  • TABLE 77. COMPANY 8: COMPANY SNAPSHOT
  • TABLE 78. COMPANY 8: OPERATING SEGMENTS
  • TABLE 79. COMPANY 8: PRODUCT PORTFOLIO
  • TABLE 80. COMPANY 8: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. COMPANY 9: KEY EXECUTIVES
  • TABLE 82. COMPANY 9: COMPANY SNAPSHOT
  • TABLE 83. COMPANY 9: OPERATING SEGMENTS
  • TABLE 84. COMPANY 9: PRODUCT PORTFOLIO
  • TABLE 85. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. COMPANY 10: KEY EXECUTIVES
  • TABLE 87. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 88. COMPANY 10: OPERATING SEGMENTS
  • TABLE 89. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 90. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 3. SEGMENTATION INTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN INTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALINTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 11. INTRAVENOUS ACCESS DEVICES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS CATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. INTRAVENOUS ACCESS DEVICES MARKET FOR CENTRALLY INSERTED CATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. INTRAVENOUS ACCESS DEVICES MARKET FOR MIDLINE PERIPHERAL CATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS INFUSION PUMPS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS NEEDLES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 21. COMPETITIVE DASHBOARD
  • FIGURE 22. COMPETITIVE HEATMAP: INTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 23. Top player positioning, 2022
  • FIGURE 24. COMPANY 1: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 25. COMPANY 1: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 26. COMPANY 1: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 27. COMPANY 2: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. COMPANY 2: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. COMPANY 2: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. COMPANY 3: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. COMPANY 3: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. COMPANY 3: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. COMPANY 4: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. COMPANY 4: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. COMPANY 4: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. COMPANY 5: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. COMPANY 5: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. COMPANY 5: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. COMPANY 6: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. COMPANY 6: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. COMPANY 6: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. COMPANY 7: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. COMPANY 7: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. COMPANY 7: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. COMPANY 8: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. COMPANY 8: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. COMPANY 8: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. COMPANY 9: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. COMPANY 9: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. COMPANY 10: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. COMPANY 10: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Intravenous Access Devices Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers